NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/23/2025
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Case type
Recorded events
Latest update
Classification
Trademark type
Nice classes
Filing date
Registration date
Expiration date
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Structured fields from the responsible authority and the official record.
Status date
Last transaction
Responsible office
Status code
Official register
Drawing code
Owner type
Owner location
Examiner
Current location
Mark description
The mark consists of the word "KOBIOLABS" in block lettering with the "KO" in the color yellow-green and the "BIOLABS" in the color gray. To the left of the word "KOBIOLABS" is a circular design shaded gray on the interior edges of the circle and transitioning to white towards the circle's interior. A green leaf is positioned in the center of the circle. The rest of the white represents background and is not part of the mark. All other white and gray in the mark represents background and shading areas and is not part of the mark.
Holders
Representatives
Hun Joon Kim LEX IP Meister, PLLC.
Nice Classes
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
[ Pharmaceutical and veterinary preparations, namely, preparations for the prevention of inflammatory bowel disease, irritable bowel syndrome, constipation, diarrhea, metabolic syndrome, obesity, diabetes, hypertension, insulin resistance, high blood cholesterol, high blood Triglycerides, cardiovascular disease, autoimmune disease, atopic dermatitis, arthritis, asthma, allergy, Crohn's disease, mental diseases, neurodegenerative disease, cancer, infectious disease, liver disease and inflammatory disease; Microorganism preparations, namely, nutritive substances for microorganisms for medical or veterinary purposes; Microorganism preparations, namely, microorganism cells for medical or veterinary purposes; Cultures of microorganisms for medical purposes; Biological preparations for medical or veterinary purposes, namely, preparations for the treatment of inflammatory bowel disease, irritable bowel syndrome, constipation, diarrhea, metabolic syndrome, obesity, diabetes, hypertension, insulin resistance, high blood cholesterol, high blood Triglycerides, cardiovascular disease, autoimmune disease, atopic dermatitis, arthritis, asthma, allergy, Crohn's disease, mental diseases, neurodegenerative disease, cancer, infectious disease, liver disease and inflammatory disease; Dietetic food supplements; Dietetic foods adapted for medical purposes; Nutraceuticals for medical purposes, namely, for the treatment of inflammatory bowel disease, irritable bowel syndrome, constipation, diarrhea, metabolic syndrome, obesity, diabetes, hypertension, insulin resistance, high blood cholesterol, high blood Triglycerides, cardiovascular disease, autoimmune disease, atopic dermatitis, arthritis, asthma, allergy, Crohn's disease, mental diseases, neurodegenerative disease, cancer, infectious disease, liver disease and inflammatory disease ]
Class 42
[ Consultation in the field of health risk assessment, namely, predicting health risks of individuals with regard to medical disease; ] Drug discovery services; [ Provision of scientific information and advice in the field of microorganisms; DNA testing for scientific research purposes; DNA analysis for scientific research purposes; DNA sequencing analysis for scientific research purposes; consultation and providing information in the fields of biomedicine for scientific and research purposes; Consultancy in analysis of biology sequence processing for medical research purposes; Consultancy in analysis of genomics for medical research purposes; ] scientific research in the fields of medicine, health and pharmacology [ ; Consultation and providing information in the fields of and pharmacology ]
Class 44
[ Performing diagnosis of diseases; Provision of genetic testing for medical treatment purposes; Provision of gene therapy for medical treatment purposes; DNA screening for medical purposes; Consultation and providing information in the fields of medicine and health ]
History of USPTO decisions and trademark events.
42 publications found
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/23/2025
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/23/2025
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/17/2025
TEAS SECTION 8 & 15 RECEIVED
06/16/2025
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/27/2024
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/27/2024
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
11/27/2024
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/27/2024
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/27/2024
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/27/2024
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/27/2024
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/02/2024
REGISTERED-PRINCIPAL REGISTER
07/02/2019
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/10/2019
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/16/2019
PUBLISHED FOR OPPOSITION
04/16/2019
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/27/2019
APPROVED FOR PUB - PRINCIPAL REGISTER
02/28/2019
TEAS/EMAIL CORRESPONDENCE ENTERED
02/26/2019
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/25/2019
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/25/2019
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/05/2018
NON-FINAL ACTION E-MAILED
09/05/2018
NON-FINAL ACTION WRITTEN
09/05/2018
EXAMINER'S AMENDMENT ENTERED
06/19/2018
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/19/2018
EXAMINERS AMENDMENT E-MAILED
06/19/2018
EXAMINERS AMENDMENT -WRITTEN
06/19/2018
TEAS/EMAIL CORRESPONDENCE ENTERED
06/09/2018
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/08/2018
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/08/2018
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/21/2017
NON-FINAL ACTION E-MAILED
12/21/2017
NON-FINAL ACTION WRITTEN
12/21/2017
EXAMINER'S AMENDMENT ENTERED
12/18/2017
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/18/2017
EXAMINERS AMENDMENT E-MAILED
12/18/2017
EXAMINERS AMENDMENT -WRITTEN
12/18/2017
ASSIGNED TO EXAMINER
12/14/2017
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/16/2017
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/15/2017
NEW APPLICATION ENTERED
09/14/2017
Continuous trademark protection
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.